StonvexLoading…
StonvexStonvexStonvexCore line items from VTAK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.04M | $432.00K | $819.00K | $581.00K | $355.00K |
Operating Income | Not available | $-2.32M | $-21.14M | $-11.28M | $-8.26M |
Net Income | Not available | $-1.68M | $-17.18M | $-11.40M | $-9.15M |
EPS (Diluted) | $-0.10 | $-1.39 | $-15.90 | $-13.02 | $-0.74 |
Total Assets | Not available | $35.09M | $15.86M | $25.47M | $25.56M |
Total Liabilities | Not available | $25.93M | $9.21M | $19.02M | $19.01M |
Cash & Equivalents | Not available | $441.00K | $88.00K | $1.07M | $838.00K |
Free Cash Flow OCF − CapEx | Not available | $-2.80M | $-8.31M | $-6.80M | $-4.62M |
Shares Outstanding | Not available | 2.69M | 1.74M | 1.65M | 18.86M |